on 11 May 2021
Last Applicant/ Owned by
The Lawns High Street, Offley
Hitchin
GB
SG53AN
Serial Number
88718586 filed on 06th Dec 2019
Registration Number
6344572 registered on 11th May 2021
Correspondent Address
Richard M. LaBarge
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; Product and scientific research and development in the field of pharmaceuticals, clinical trials, clinical research, medical devices and biotechnology; Consultancy services for others in the field of technical consultancy for pharmaceuticals, design, planning Read More
Managed healthcare services being medical services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; consultancy services in the field of medical information services; medical consultancy services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; consultancy services in the field of biotechnology diagnostics and pharmacogenetics diagnostics medical testing; medical information, advice and consultancy services in the pharmaceutical and healthcare sectors; medical information, advice and consultancy services in relation to pharmacovigilance; information, advice and consultancy services in relation to all the aforesaid services
Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; Product and scientific research and development in the field of pharmaceuticals, clinical trials, clinical research, medical devices and biotechnology; Consultancy services for others in the field of technical consultancy for pharmaceuticals, design, planning, and implementation consultancy for clinical trials, consultancy on scientific clinical research, and design and development consultancy for medical devices; conducting early evaluations in the field of new pharmaceuticals; consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics; medical and scientific research; conducting clinical trials for others; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development; product development consultancy in the field of pharmaceuticals and biotechnology; testing and quality control evaluation of products in the field of pharmaceuticals, clinical trials and biotechnology; product testing and quality control evaluation of pharmaceutical preparations and medicines; testing and quality control in the nature of conducting clinical trials in the field of pharmaceuticals and biotechnology for others; Software as a Service (SaaS) featuring software for use as a database and for analysing data in the fields of in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; providing online non-downloadable software applications for use in creating, designing, hosting, publishing, managing and maintaining content for use on the internet for website and media content management purposes; application service provider featuring application programming interface (API) software to allow people to view data through an interactive map, to query data, to generate reports and to access data and documents; software as a service (SAAS) featuring computer software to enable the displaying, receiving and transmitting of data to enable the purchase of goods and services; information, advice and consultancy services in relation to all the aforesaid services
Providing Internet access, namely, providing access to platforms and portals on the internet in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; providing user access to global computer networks, namely, providing user access to platforms and portals on the internet in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; information, advice and consultancy services in relation to all the aforesaid services
Business project and risk management services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; business consultancy services; Business project and risk management and consultancy services in the field of clinical trials and clinical research; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management services for medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing business information management services on clinical trials and clinical research; providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; providing business management information in connection with consultancy and advisory services in the field of strategic planning; regulatory submission management, namely, business strategic planning, and preparing and submitting applications for others for new medical devices, new pharmaceuticals, variations on previously approved medical devices, and variations on previously approved pharmaceuticals to receive clinical trial approval or marketing authorization from governmental regulatory bodies; regulatory submission management, namely, assisting others with strategic business planning, and preparing and filing applications with governmental regulatory bodies for approval of new medical devices and new pharmaceuticals; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; New pharmaceutical and biotechnology product commercialization services; consultancy services for others in the field of new pharmaceutical and biotechnology product commercialization; information, advice and consultancy services in relation to all the aforesaid services
Downloadable and recorded computer software for use as a database and for analysing data in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology; Downloadable software applications for computers, laptops and mobile phones featuring software for use as a database and for collating, storing, analysing, and utilizing data in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology; Downloadable and recorded software for secure data storage and retrieval and transmission of customer and client information; Downloadable and recorded computer software for use as a database and for collating, storing, analysing and utilizing data in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; downloadable and recorded computer operating programs and downloadable and recorded application development software for use on or in connection with mobile phones, tablets and handheld devices in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; data processing equipment and computers; Downloadable electronic publications in the nature of e-books, magazines, newsletters and reports provided on-line from a database or the internet in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology
No 88718586
No Service Mark
No 32198/62199
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
11th May 2021 | REGISTERED-PRINCIPAL REGISTER |
23rd Feb 2021 | PUBLISHED FOR OPPOSITION |
23rd Feb 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
03rd Feb 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
21st Jan 2021 | EXAMINERS AMENDMENT -WRITTEN |
21st Jan 2021 | EXAMINERS AMENDMENT E-MAILED |
21st Jan 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
21st Jan 2021 | EXAMINER'S AMENDMENT ENTERED |
21st Jan 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
19th Jan 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |